AMA: PBM Market Concentration Is On the Rise

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 01 Oct, 22:38 UTC

The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in 2024. The post AMA: PBM Market Concentration Is On the Rise appeared first on MedCity News.

science

Sources

• T2AMA: PBM Market Concentration Is On the RiseFierce Biotech / Fierce Healthcare / MedCity / GEN01 Oct, 22:38